Achilles Therapeutics
Achilles Therapeutics is a biopharmaceutical company that develops personalized T cell and cancer immunotherapies. The company was founded in 2016 and is headquartered in London, England.
Last updated on
About Achilles Therapeutics
Founded
2016Estimated Revenue
$50M-$100MEmployees
51-250Funding / Mkt. Cap
$216MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
87NAICs Code
54Location
City
LondonState
Greater LondonCountry
United KingdomTech Stack (71)
